The Randomized Controlled Trial for Evaluating the Efficacies of Tolvaptan in Patients with ascites in hepatic edema
Phase of Trial: Phase II
Latest Information Update: 16 Sep 2016
Price : $35 *
At a glance
- Drugs Tolvaptan (Primary) ; Furosemide
- Indications Ascites; Liver cirrhosis
- Focus Therapeutic Use
- 31 Aug 2016 Status changed from recruiting to completed.
- 27 Apr 2015 Planned End Date changed to 10 Mar 2016 as reported by UMIN record.
- 30 Sep 2014 New trial record